ALHC

SEC source: 0001628280-24-031965 · wk-form4_1721161803.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 406,912

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $9.00 to $9.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-24-031964 · wk-form4_1721161755.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,916,097

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.89 to $9.21. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-24-032009 · wk-form4_1721176176.xml · nonDerivative · entry 2

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,233,221

SEC source: 0001628280-24-031965 · wk-form4_1721161803.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 421,946

SEC source: 0001628280-24-031964 · wk-form4_1721161755.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,955,797

SEC source: 0001628280-24-032009 · wk-form4_1721176176.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,255,621

SEC source: 0001628280-24-031190 · wk-form4_1720042618.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,246

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-24-028666 · wk-form4_1718670523.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 415,933

F1 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee.

SEC source: 0001628280-24-028667 · wk-form4_1718670550.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 422,912

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-24-028359 · wk-form4_1718401783.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,956,097

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.06 to $8.40. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005138 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,976,097

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005137 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 865,407

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005139 · doc4.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 436,822

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005136 · doc4.xml · nonDerivative · entry 1

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430,444

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-034810 · wk-form4_1752268473.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,888,586

F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction. Vesting occurred on 3/25/2024 and the transaction is being reported late due to an inadvertent administrative oversight.

F2 · balance_after: Reflects the number of shares beneficially owned as of the date of this Form 4. The number of shares beneficially owned immediately following the reported transaction was 2,710,653.

SEC source: 0001209191-24-005039 · doc4.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,986,248

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0001209191-24-005037 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,912

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005039 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,999,500

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005034 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 869,706

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005038 · doc4.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,643

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005036 · doc4.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 555,530

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-005035 · doc4.xml · nonDerivative · entry 1

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 434,807

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-004874 · doc4.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,015,361

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-004871 · doc4.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 898,228

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-004884 · doc4.xml · nonDerivative · entry 2

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 441,721

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-004870 · doc4.xml · nonDerivative · entry 2

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,771

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-24-004895 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,745,253

F1 · kind: The transaction reported on this Form 4 is an open-market purchase by the reporting person of 103,000 shares of common stock at a weighted-average purchase price per share of $4.8231.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were purchased in multiple transactions at a per share price ranging from $4.77 to $4.87. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.

SEC source: 0001209191-24-004886 · doc4.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,451

F1 · kind: Represents 30,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0000950142-24-000721 · es240458832_4-alhc1.xml · nonDerivative · entry 1

GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner

GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner

General Atlantic Partners 95, L.P. · CIK 0001606259 · Director · 10% owner

GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner

GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner

GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner

GAPCO GMBH & CO KG · CIK 0001187388 · Director · 10% owner

GAPCO MANAGEMENT GMBH · CIK 0001187390 · Director · 10% owner

GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner

General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 61,264,755

F2 · kind: Represents 50,000 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · kind: Represents 50,000 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

F1 · ownership.nature: The securities are held solely for the benefit of General Atlantic Service Company, L.P. ("GASC"), which is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee?*). Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. *The Partnership Committee is formerly the Management Committee, with composition effective pending applicable regulatory approvals.

F2 · ownership.nature: Represents 50,000 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · ownership.nature: Represents 50,000 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-24-004872 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 463,972

F1 · shares: Represents (i) 130,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 10,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 56,138 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

SEC source: 0001209191-24-004880 · doc4.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,763

F1 · shares: Represents 60,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-24-004868 · doc4.xml · nonDerivative · entry 1

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,945

F1 · shares: Represents 100,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0000950142-24-000722 · es240458833_4-alhc2.xml · nonDerivative · entry 1

General Atlantic (ALN HLTH), L.P. · CIK 0001853603 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 61,264,755

F2 · kind: Represents 50,000 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · kind: Represents 50,000 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

F1 · ownership.nature: The securities are held solely for the benefit of General Atlantic Service Company, L.P. ("GASC"), which is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee?*). Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. *The Partnership Committee is formerly the Management Committee, with composition effective pending applicable regulatory approvals.

F2 · ownership.nature: Represents 50,000 restricted stock units which were granted to David C. Hodgson, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Hodgson ceases to serve as a member of the Board of Directors prior to such date.

F3 · ownership.nature: Represents 50,000 restricted stock units which were granted to Nicholas Robbert Vorhoff, who is an employee of GASC and director of the Issuer, on March 13, 2024, each restricted stock unit representing a right to receive one share of Common Stock of the Issuer, all of which will vest on the one-year anniversary of the grant date unless Mr. Vorhoff ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-24-004874 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,036,898

F1 · shares: Represents (i) 130,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 41,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 35,890 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

SEC source: 0001209191-24-004871 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 910,086

F1 · shares: Represents (i) 110,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 21,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 69,710 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

SEC source: 0001209191-24-004885 · doc4.xml · nonDerivative · entry 1

McCarthy Margaret M · CIK 0001485980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,620

F1 · kind: Represents 33,500 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

SEC source: 0001209191-24-004873 · doc4.xml · nonDerivative · entry 1

CARELLA THOMAS J. · CIK 0001477767 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,478

F1 · kind: Represents 40,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-24-004881 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,642,253

F1 · kind: Represents 330,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-24-004879 · doc4.xml · nonDerivative · entry 1

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,609

F1 · kind: Represents 40,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, until separation from service or a change of control of the Company).

SEC source: 0001209191-24-004875 · doc4.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,258,221

F1 · kind: Represents 70,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

SEC source: 0001209191-24-004877 · doc4.xml · nonDerivative · entry 1

BILNEY JODY L · CIK 0001185995 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,744

F1 · kind: Represents 40,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation from service (or, if earlier, until change of control of the Company).

SEC source: 0001209191-24-004882 · doc4.xml · nonDerivative · entry 1

JORDEN YON · CIK 0001189397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,476

F1 · kind: Represents 30,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-24-004869 · doc4.xml · nonDerivative · entry 1

HODGSON DAVID C · CIK 0001193346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,716

F1 · kind: Represents 50,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company). The restricted stock units granted to the reporting person are held by him solely for the benefit of General Atlantic Service Company, L.P. The reporting person disclaims beneficial ownership of the restricted stock units and the underlying Common Stock.

SEC source: 0001209191-24-004878 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 345,177

F1 · kind: Represents 30,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-24-004876 · doc4.xml · nonDerivative · entry 1

Vorhoff Nicholas Robbert · CIK 0001794455 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,716

F1 · kind: Represents 50,000 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company). The restricted stock units granted to the reporting person are held by him solely for the benefit of General Atlantic Service Company, L.P. The reporting person disclaims beneficial ownership of the restricted stock units and the underlying Common Stock.

SEC source: 0001209191-24-004883 · doc4.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 561,106

F1 · shares: Represents (i) 140,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 4,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 14,970 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

SEC source: 0001209191-24-004884 · doc4.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,573

F1 · shares: Represents (i) 70,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 10,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

SEC source: 0001209191-24-004870 · doc4.xml · nonDerivative · entry 1

Kardes Hakan · CIK 0001975023 · Chief Experience Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,097

F1 · shares: Represents (i) 70,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 18,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 52,190 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year.

SEC source: 0001628280-25-024341 · wk-form4a_1746824467.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,275,221

F1 · shares: Represents 17,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

SEC source: 0001209191-24-004789 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,830,008

F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.39 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.